HERVolution Therapeutics Appoints Dr. László B. Tankó to Scientific Advisory Board to Strengthen Cardiometabolic Clinical Development Strategy
PRNewsWire
·
2026-04-28
·
via The Tech Buzz - Press Releases
Industry veteran brings 25+ years of global clinical leadership from Ferring, Novartis, NIBR, Bayer, and SixPeaks Bio to support HERVolution's cardiometabolic pipeline Tankó's strategic scientific exp
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。